Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Dr. Patel, director of Mayo Clinic's Infectious Diseases Research Laboratory, discussed the future of testing for joint and bone infections.
In a recent "Answers From the Lab" podcast, Aaron Tande, M.D., an infectious disease specialist and associate chair for outpatient practice in Mayo Clinic's Division of Infectious Diseases, explains the algorithm Mayo has developed to make sure patients receive the right test at the right time, so they can get the care they need as quickly as possible.
This week’s research roundup features a study on how CRM1 inhibitor anti-tumor activity is enhanced with salicylates by S-phase arrest and impaired DNA-damage repair.
Due to the Thanksgiving Day holiday (recognized on Thursday, November 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan ahead.
Top highlights include: how contact tracing has evolved, mentally surviving the imperfect storm that is 2020, keeping those at the highest risk of COVID-19 safe during the latest surge, and debunking COVID-19 myths.
In this episode of Lab Medicine Rounds, Charles Sturgis, M.D., Professor in the Department of Laboratory Medicine and Pathology and Program Director of our Anatomic and Clinical Pathology Residency program at Mayo Clinic, discusses ways for students to prepare for their pathology residency interviews.
The following list includes updates posted to mayocliniclabs.com during the month of October.
In October 2020, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Dr. Bornhorst explains orexin testing's role in diagnosing type 1 narcolepsy and the significance of the test's availability through Mayo Clinic Laboratories.
Min Shi, M.D., Ph.D., a hematologist and co-director of Mayo Clinic's Flow Cytometry Laboratory, explains recent updates to the B-cell lymphoblastic leukemia minimal residual disease flow cytometry assay. This test is used to identify minimal residual disease in patients with a previously confirmed diagnosis of B-cell lymphoblastic leukemia who have completed chemotherapy, immunotherapy or bone marrow transplantation.
This week’s research roundup features a study on the development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the International Staging Collaboration for Cancer of the Prostate.
Top highlights include: pediatric inflammatory syndrome linked to COVID-19 also discovered in adults, CDC updates close contact guidelines, and what to know about this season's flu vaccine.